Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$7.549 -0.54%
Market Cap
$15.4M
Price Target
Refer to Report
Volume
50.6K
52wk Range
$6.0101 - $91.2475
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.